Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;52(1):19-23.
doi: 10.4111/kju.2011.52.1.19. Epub 2011 Jan 24.

Neoadjuvant hormonal therapy preceding radical prostatectomy for clinically localized prostate cancer: early postoperative complications and biochemical recurrence

Seung Woo Yang  1 , Ki Hak Song, Jae Sung Lim, Chong Koo Sul
Affiliations

Neoadjuvant hormonal therapy preceding radical prostatectomy for clinically localized prostate cancer: early postoperative complications and biochemical recurrence

Seung Woo Yang et al. Korean J Urol. 2011 Jan.

Abstract

Purpose: The effect of neoadjuvant hormonal therapy (NHT) on radical retropubic prostatectomy (RRP) for prostate cancer is various and remains a controversy for urologists. We conducted this study to comparatively evaluate whether NHT before RRP is indicated and beneficial in the aspects of postoperative complications, positive surgical margin, and biochemical recurrence.

Materials and methods: Between September 2006 and December 2009, 69 men were scheduled for RRP as a treatment for clinically localized and locally advanced prostate cancer and were divided into two groups. Group 1 (n=31, 44.9%) was treated with RRP only, and group 2 (n=38, 55.1%) underwent RRP with preoperative NHT. We evaluated clinical parameters, surgical parameters, and the positive margin rate in surgical specimens and the biochemical recurrence rate.

Results: There were no statistical differences in age, body mass index (BMI), preoperative biopsy Gleason score, initial serum prostate-specific antigen (PSA) levels, International Prostate Symptom Score (IPSS), or quality of life (QoL) between the two groups (p>0.05). We also observed no differences in the transfusion rate, mean catheterization time, or positive margin rate (p>0.05). However, the mean operative time was significantly higher in the RRP with preoperative NHT group than in the other group (p=0.034). There was no significant difference in the biochemical recurrence rate during the last follow-up according to NHT (p=0.102) or positive surgical margin (p=0.473).

Conclusions: These results suggest that there were no clinical benefits to the administration of NHT before RRP from the viewpoint of biochemical recurrence.

Keywords: Neoadjuvant therapy; Prostatectomy; Prostatic neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

FIG. 1
FIG. 1
Kaplan-Meier curves for prostate-specific antigen (PSA) recurrence free survival until PSA failure according to treatment regimen. Biochemical recurrence rate does not show any significant difference between 2 arms. log-rank test, p=0.102.
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
    1. Jani AB, Hellman S. Early prostate cancer: clinical decision-making. Lancet. 2003;361:1045–1053. - PubMed
    1. Macfarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrun A, deKernion JB. Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol. 1993;150:132–134. - PubMed
    1. Paulson DF. Neoadjuvant androgen-deprivation therapy prior to radical prostatectomy: con. Urology. 1996;48:539–540. - PubMed
    1. Song J, Chang K. Current status of hormonal therapy for prostate cancer in Korea: a national survey of Korean uro-oncologists. Korean J Urol Oncol. 2003;1:175–180.

LinkOut - more resources